In conclusion, these data show that inhibition of both the VEGF and EGFR pathways demonstrates efficacy in NSCLC xenografts and that combining such agents with radiation could improve the anti-tumour activity of radiation alone. This evidence concerns the gene EGFR and neoplasm.